There is on-going development of  generic EU CTD Dossier of  Levocetirizine, tablets.
Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights.

• Cooper Pharma Ltd. (08/01/2009)
• 3rd Annual Biosimilars conference (24/11/2008)
• Croatia - Pharmaceuticals and Biotechnology (18/10/2008)

• NeOpuntia® (30/12/2005)
• Table Salt Substitute (29/12/2005)
• Ginkgo biloba (18/12/2005)
• Cetirizine, oral solution (16/12/2005)